ITRM vs GILD: Which Stock is Better?

Side-by-side comparison of Iterum Therapeutics Plc and Gilead Sciences Inc in 2026

Comparison Updated:

ITRM

Iterum Therapeutics Plc

$0.03

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricITRMGILDWinner
Market Cap$1.60M$171.97BGILD
P/E RatioN/A20.44GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth-1.0%0.0%GILD
Gross Margin29.7%78.8%GILD

Analyze ITRM

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ITRM or GILD a better investment?

Comparing ITRM and GILD: Iterum Therapeutics Plc has a market cap of $1.60M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ITRM and GILD?

ITRM (Iterum Therapeutics Plc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ITRM or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ITRM or GILD?

GILD has higher revenue growth at 0.0% vs -1.0% for ITRM.

Which company is more profitable: ITRM or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 29.7% for ITRM.

Which is the larger company: ITRM or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $1.60M for ITRM.

Should I buy ITRM or GILD in 2026?

Both ITRM and GILD have investment merit. ITRM trades at $0.03 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ITRM and GILD stock?

Key differences: Market Cap ($1.60M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (29.7% vs 78.8%).

Popular Stock Comparisons